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Abstract 
Postpartum posterior pelvic girdle pain (PPGP) affects nearly 20 % of women who experience back pain in the peri-
partum period. The sacroiliac joint is a source of this pain in 75 % of women with persistent PPGP. A subset of women 
will fail to obtain acceptable pain relief from the current array of non-surgical treatment options. The purpose of this 
study is to assess the safety and effectiveness of minimally invasive sacroiliac (SI) joint fusion in women with chronic 
SI joint dysfunction whose pain began in the peri-partum period whose symptoms were recalcitrant to non-surgical 
management. A sub-group analysis of subjects with sacroiliac joint disruption and/or degenerative sacroiliitis enrolled 
in a prospective, multi-center trial of SI joint fusion was performed. Subjects with PPGP were identified and com-
pared with women without PPGP and with men. Of 172 enrolled subjects, 52 were male, 100 were females without 
PPGP and 20 females had PPGP. PPGP subjects were significantly younger (43.3 years, vs. 52.8 for females without 
PPGP and 50.5 for men, p = 0.002). There were no differences in any other demographic or baseline clinical measure. 
Women with PPGP experienced a significant improvement in pain (−51 mm on VAS), function (−20.6 pts on ODI) 
and quality of life (SF-36 PCS +10.4, MCS +7.2, EQ-5D +0.31) at 12 months after surgery. These improvements were 
characteristic of the overall study results; no difference was detected between sub-groups. The sacroiliac joint can be 
a source of pain in women with persistent PPGP and should be investigated as a pain generator. In this study, women 
with carefully diagnosed chronic SI joint pain from PPGP recalcitrant to conservative therapies experienced clinically 
beneficially improvements in pain, disability and quality of life after minimally invasive SI joint fusion using a series of 
triangular porous plasma spray coated implants.
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Background
Pelvic girdle pain (PGP) is a term used to describe preg-
nancy-related pain in the sacroiliac joint (SIJ), lumbosa-
cral region, pubic symphysis, or in any combination of 
these joints. PGP is widespread, affecting nearly half of all 
pregnant women (Vleeming et al. 2008; Wu et al. 2004). 
PGP can be distinguished from pregnancy related low 
back pain (PLBP) by its character, intensity, and location; 
PLBP is mainly described as a “dull ache” in the lumbar 
region while PGP is mostly described as pain between 
the posterior iliac crest and gluteal fold that may radi-
ate into the thigh (Gutke et al. 2008; Vermani et al. 2010). 
While PGP will resolve in most women within 4 months 
after giving birth, approximately 20  % of women will 
experience persistent symptoms, regardless of culture or 
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economic condition (Aldabe et  al. 2012; Björklund and 
Bergström 2000; Ostgaard and Andersson 1992). Pelvic 
girdle pain that begins during pregnancy and does not 
resolve, or pain that develops soon after pregnancy is 
termed postpartum pelvic girdle pain (PPGP) (Vermani 
et al. 2010).
The exact underlying pathophysiology of PPGP remains 
unclear, although the most likely explanation is a combi-
nation of hormonal and biomechanical factors (Vermani 
et al. 2010). Hypermobility and ligamentous laxity of the 
SI joint due to increased levels of estrogen and relaxin 
appear in the third trimester of pregnancy (Dreyfuss 
et  al. 2004). These altered hormonal factors allow the 
pelvic girdle to slightly expand in order to accommodate 
parturition. The most noticeable joint changes (iden-
tified radiographically) occur in the pubic symphysis. 
The joint widens and vertically shifts during pregnancy 
and delivery, with subsequent reduction after delivery 
(Björklund et  al. 1999). Interestingly, neither increased 
relaxin levels peripartum nor degree of symphyseal dis-
tention have been shown to be a factors in the develop-
ment of pelvic girdle pain (Aldabe et al. 2012; Björklund 
et al. 1999). Factors that have been shown to increase the 
risk of pelvic girdle pain include pre-pregnancy back pain 
(Sjödahl et  al. 2013), back flexor weakness (Gutke et  al. 
2008), body mass index (Sjödahl et  al. 2013), hypermo-
bility, asymmetric SI joint ligament laxity (Damen et  al. 
2001), emotional distress (Bjelland et al. 2013), and vagi-
nal delivery (Bjelland et al. 2013).
The current array of non-surgical PPGP treatments 
include medication optimization, physical therapy, and 
an individualized exercise regimen focused on pelvic sta-
bilization (Vleeming et  al. 2008). The European Guide-
lines for the Diagnosis and Treatment of Pelvic Girdle 
Pain do not recommend radiofrequency denervation; 
intra-articular SIJ injections are recommended only in 
the presence of ankylosing spondylitis (Vleeming et  al. 
2008). Neither of these have been specifically studied in 
the PPGP population.
Minimally invasive (MIS) SI joint fusion is an increas-
ingly popular surgical treatment option for patients 
suffering from certain SI joint disorders (Rudolf 2012; 
Duhon et al. 2013; Sachs and Capobianco 2013; Graham 
Smith et  al. 2013). Sacroiliac joint fusion investigation 
(SIFI, NCT01640353) is a prospective, multicenter sin-
gle-arm clinical trial of MIS SI joint fusion using trian-
gular-shaped titanium implants (iFuse Implant System®, 
SI-BONE, Inc., San Jose, CA, USA) in patients with SI 
joint disruption and/or degenerative sacroiliitis. The pur-
pose of the present study is to assess the safety and effec-
tiveness of MIS SI joint fusion in a subgroup of patients 
with degenerative sacroiliitis and/or SI joint disruptions 
whose pain began in the peri-partum period.
Methods
Patient population
At 26 centers across the US, 172 patients with diag-
nosed SI joint pain due to degenerative sacroiliitis and/
or SI joint disruption were enrolled and treated in the 
SIFI study (NCT01640353) (Duhon et al. 2013). Partici-
pants were men and women between the ages of 21 and 
70 who failed to achieve acceptable symptom relief after 
a minimum of 6  months of conservative care. Prior to 
study entry, patients were required to have undergone a 
complete diagnostic work up that included five physical 
examination maneuvers that stress the SI joint (Table 1) 
and an image-guided intra-articular SI joint block using 
local anesthetic. Eligibility required a positive response 
on 3 of 5 provocative maneuvers and at least 50 % reduc-
tion of SI joint pain after the injection. Further eligibility 
criteria included a score of at least 30 % on the Oswestry 
Disability Index (ODI) and a minimum SI joint pain rat-
ing of 50 mm on a 0–100 mm visual analog scale (VAS). 
The results of these examinations were recorded for the 
as baseline study parameters. Patients were excluded 
from study participation if they had severe low back pain 
as a result of diagnosed lumbar spinal pathology (e.g., 
lumbar disc degeneration, spinal stenosis, etc.), pain from 
known hip pathology, history of recent (<1  year) major 
trauma to the pelvis, or metabolic bone disease (either 
induced or idiopathic). Patients were also ineligible if 
they were receiving worker’s compensation or disabil-
ity payments or involved in litigation for back or SI joint 
pain. After providing written informed consent, subjects 
underwent minimally invasive SI joint fusion using the 
iFuse Implant System as previously described (Rudolf 
2012; Duhon et al. 2013). The study was IRB-approved at 
all clinical sites before enrollment began.
A medical history, neurological exam focused on the 
lower spine and pelvis, and a series of self-reported ques-
tionnaires were obtained at baseline. At postoperative 
follow-up visits, subjects underwent a neurological exam, 
adverse event assessment and were required to complete 
the same self-reported questionnaires. Self-reported 
questionnaires included SI joint and low back pain as 
measured on a visual analog scale (VAS), disability due 
to back pain using the Oswestry Disability Index (ODI), 
and quality of life using both EuroQol-5D (EQ-5D) 
and the Short Form-36 (SF-36). VAS was captured on a 
0–100 mm unmarked scale with 0 representing no pain 
and 100 representing the worst pain imaginable. ODI is 
a validated ten-question survey for disability due to back 
pain. EQ-5D is a 5-question broad quality of life meas-
ure that can be combined into a single that represents 
the time trade-off (TTO) utility of current health (Euro-
Qol Group 1990). SF-36 is a 36-question 8-subscaled 
generic quality of life measure that produces both a 
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summary physical component score (PCS) and summary 
mental component score (MCS) (Ware and Sherbourne 
1992). These measures are scaled such that the popula-
tion norm is approximately 50 with a standard deviation 
of 10. Female subjects were classified as PPGP if they 
indicated that their pain began in the peripartum period. 
In the context of diagnosed SI joint pain, it is assumed 
that these women have pregnancy-related disruption or 
degeneration of the SI joint.
Surgical procedure
MIS SI joint fusion, performed in all subjects within 
30 days of the baseline assessment, was completed under 
intraoperative fluoroscopic guidance. After general 
endotracheal anesthesia was administered, the patient 
was turned prone on a radiolucent table. A 3–5 cm lateral 
incision was made into the buttock region and the glu-
teal fascia was bluntly dissected to reach the outer table 
of the ilium. A guide pin was passed through the ilium 
Table 1 Physical provocative maneuvers
Test Description Example
Distraction
The patient lies supine and is asked to place their forearm behind their 
lumbar spine to support the natural lordosis.  A pillow is placed under the 
patients knees.  The examiner places their hands on the anterior and medial 
aspects of both of the patient’s anterior superior iliac spines (ASIS) with 
arms crossed.  A slow and steady increasing pressure is placed through the 
arms and held.
Compression
The patient is placed in a side lying position, facing away from the 
examiner, with a pillow between the knees.  The examiner places a 
downward pressure through the lateral aspect of the patients top side ASIS 
and pelvis, anterior to the greater trochanter.
FABER test
(Patrick’s test) 
The patient lies supine as the examiner crossed the same side foot over the 
opposite side thigh.  A force is steadily increased through the knee of the 
patient, exaggerating the motion of hip flexion, abduction, and external 
rotation.  The pelvis is stabilized at the opposite ASIS with the hand of the 
examiner.
Thigh Thrust
The patient lies supine with one hip flexed to 90 degrees.  The examiner 
stands on the same side as the flexed leg.  The examiner provides either a 
quick thrust or a steady increasing pressure through the line of the femur.  
The pelvis is stabilized at the opposite ASIS with the hand of the examiner.
Gaenslen’s test
The patient lies supine with the near side leg hanging off the table.  The 
patient is asked to hold the opposite side knee into flexion.  The examiner 
applies an extension force to the near side thigh and a flexion force to the 
opposite knee.  The patient assists with opposite side hip flexion.  This is 
performed bilaterally.  
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across the SI joint to the center of the sacral ala, lateral 
to the neural foramen. A soft tissue protector was passed 
over the pin, and a drill was used to create a pathway into 
the sacrum and decorticate the bone. A triangular broach 
was then used to further decorticate the bone and pre-
pare a pathway to receive the implant. Using a pin guid-
ance system, additional implants were placed across the 
SI joint. In general, three implants are placed across the 
joint. The most cephalad implant was typically seated 
within the sacral ala above the S1 foramen. The second 
implant was generally located above or adjacent to the 
S1 foramen and the third between the S1 and S2 fora-
men (Fig.  1). The incision was irrigated and the tissue 
layers sequentially closed. Subjects who required treat-
ment of both SI joints were offered either bilateral same-
day or staged surgery. Perioperative measures, including 
estimated blood loss, fluoroscopy time, operating time, 
number of implants used, and complications, were 
collected.
Postoperatively, subjects were asked to remain at heel-
toe touch-down weight-bearing using a front-wheeled 
walker or crutches for 3  weeks followed by progressive 
ambulation with crutches until fully ambulatory. Begin-
ning 1–3  weeks postoperatively, subjects were asked to 
undergo individualized physical therapy twice a week 
for 6 weeks. Physical therapy involved activity modifica-
tion to minimize pain recurrence, mobility and stability 
exercises, and adjacent segment joint mobilization for 
stiffness and pain control. Manipulation of the treated SI 
joint was discouraged.
Outcome measures
The study’s primary endpoint was a binary success/failure 
composite endpoint at 6  months post-operatively. Suc-
cess was defined if all of the following criteria were met: 
reduction in VAS SI joint pain by at least 20  mm, and 
absence of (1) serious device related adverse events, (2) 
neurological adverse events related to the study device, 
and (3) re-operation for any reason. Secondary outcome 
measures included change from baseline on VAS, ODI, 
EQ-5D, and SF-36 scores (individual components and 
PCS/MCS) at post-operative time points. Study follow-
up will continue out to 2 years.
Statistical analysis
An exact binomial confidence limit for the 6-month suc-
cess proportion was calculated and compared with an 
estimate of the success rate with no treatment in this 
patient population, estimated at 35 %. A repeated meas-
ures analysis of variance was used to evaluate changes 
from baseline in pain, ODI, EQ-5D and SF-36. Logistic 
regression was used to compare the success rate in the 
PPGP group to both women without PPGP and men. 
Adverse event rates were tabulated. The number of 
adverse events per subject was compared with Poisson 
regression. All statistical analyses were performed using 
R (R Core Team 2013).
Results
Of 172 subjects treated, 52 were male and 120 were 
female. Of the 120 women, 20 subjects (16.7 % of females, 
11.6  % of all subjects) indicated that pain began in the 
peripartum period (Table 2). This constitutes the popula-
tion designated as PPGP. Subjects with PPGP were sig-
nificantly younger than both women without PPGP and 
men (mean 43.3  years vs. 52.5 and 50.7, respectively, 
p  =  0.002). There was no difference in BMI (28.7) or 
duration of pain (6.3 years) between women with or with-
out PPGP, or men. A slightly smaller proportion of PPGP 
Fig. 1 a Pelvic AP and b lateral plain film radiographs showing three 
implants placed across the SI joint
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patients (30 %) had previously undergone lumbar spinal 
fusion, compared to women without PPGP (42.2 %) and 
men (51.6  %, p  =  0.206). Prior to study enrollment, all 
subjects had undergone a minimum 6-month course of 
conservative treatment and more than half of all patients 
underwent a course of physical therapy. More men than 
women with or without PPGP were treated with RF abla-
tion prior to study entry (10  % PPGP, 14.4  % women 
without PPGP, 19.4 % men, p = 0.05). Baseline scores on 
all patient-reported outcome questionnaires did not dif-
fer between groups. Operative characteristics are sum-
marized in Table 3.
Women with PPGP experienced a significant improve-
ment in pain, function and quality of life after SI joint 
surgery (Table 4). Compared to the baseline mean VAS 
pain level (81.9), pain in the PPGP subgroup was reduced 
by 51.1 points at 12 months (0–100 mm scale, p < .0001) 
(Fig. 2). Minimal clinically important difference, defined 
as a ≥20  mm change from baseline, was observed in 
94.7  % of PPGP subjects. Disability measured on ODI 
improved by 20.6 points at 12-months; the mean score 
decreased from 52.2 at baseline to 30.4 at 6 months and 
32.8 at 12 months (p < .0001) (Fig. 3). The physical com-
ponent score (PCS) of the SF-36 increased significantly 
(higher scores represent better quality of life) from 32 
at baseline to 40 at 6-months and 41.6 at 12-months 
(p =  .002), reflecting an improvement in quality of life 
of approximately 1 SD (Fig. 4). Mean EQ-5D time trade-
off (TTO) utility score improved from 0.42 at baseline to 
0.72 at both 6- and 12-months, an improvement of 0.31 
points (p < .0001). All of these improvements were typi-
cal of the larger study population. EQ-5D TTO, SF-36 
PCS and MCS showed statistically significant effects 
across groups. Nearly all patients were very or somewhat 
satisfied with surgery at 1  year post-operatively (100  % 
PPGP, 84.0  % women without PPGP, 91.3  % men) and 
reported they might or definitely would have surgery 
again (94.1 % PPGP, 89.4 % women without PPGP, 93.5 % 
men).   
Adverse events, defined according to an international 
clinical trial standard (ISO14155: 2011), were collected 
at every study time point as well as any time the subject 
was in contact with the investigator’s office. Investiga-
tors were asked to determine the severity and relation-
ship to the study device and surgical procedure for each 
event. Severity was classified as mild, moderate or severe. 
Relatedness was categorized as definitely, probably, pos-
sibly, unlikely or unrelated to the device or procedure. A 
total of 283 adverse events occurred between enrollment 
and the 12-month visit: 37 in women with PPGP, 158 in 
women without PPGP and 88 in men (Table  5). Most 
adverse events were related neither to the study device 
or study procedure. There was no difference in the mean 
number of events per subject between groups. Across 
the entire study population, 21 events were classified as 
definitely or probably related to the device or procedure: 
4 in the PPGP group, 10 in women without PPGP and 7 
Table 2 SIFI enrolled subject demographics
* ANOVA
† Chi squared
PPGP (n = 20)  
mean (SD)
No PPGP (n = 100) Men (n = 52)
Age (years) 43.3 (9.0) 52.5 (11.1) 50.7 (11.4) p = 0.002
BMI 28.7 (7.1) 29.4 (7.9) 29.5 (5.8) p = 0.88*
Pain duration (years) 6.3 (7.4) 4.8 (5.3) 5.2 (7.2) p = 0.62*
Prior lumbar fusion (%) 6 (30 %) 38 (42.2 %) 32 (51.6 %) p = 0.21†
Prior treatments (n, %)
 Physical therapy 13 (65 %) 60 (66.7 %) 38 (61.3 %) p = 0.79†
 RF ablation 2 (10 %) 13 (14.4 %) 12 (19.4 %) p = 0.05†
 Steroid injections 20 (100 %) 87 (96.7 %) 55 (88.7 %) p = 0.06†
Table 3 Operative characteristics
Characteristic Value
Target joint, n (%)
 Right 83 (48.3 %)
 Left 89 (51.7 %)
Procedure time, min
 Mean (SD, range) 46.4 (16.1)
Fluoroscopy time, min
 Mean (SD, range) 2.7 (1.8)
Estimated blood loss, cc
 Mean (SD, range) 51 (76)
Hospital length of stay, days
 Mean (SD, range) 0.8 (0.97, 0–7)
  Discharged same day 69 (40.1 %)
   1 85 (49.4 %)
   2 10 (5.8 %)
   3 or more 8 (4.7 %)
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Table 4 Patient reported outcomes
Study success PPGP No PPGP Men
N Successful (%) N Successful (%) N Success-
ful (%) 
Success at 6 months 19 18 (94.7 %) 100 78 (78.0 %) 50 40 (80.0 %)
Success at 12 months 17 13 (76.5 %) 95 74 (77.9 %) 46 38 (82.6 %)
PPGP No PPGP Men
N Mean (SD) N Mean (SD) N Mean (SD)
VAS SI pain
 Baseline 20 81.9 (10.0) 100 79.9 (13.3) 52 78.9 (12.9)
 1 month 20 31.6 (25.3) 98 38.9 (26.7) 50 35.2 (26.2)
 3 months 20 36.0 (24.4) 99 29.6 (26.3) 50 30.6 (26.0)
 6 months 19 21.3 (17.6) 100 31.5 (27.0) 50 30.2 (28.0)
 12 months 17 31.4 (30.9) 94 32.7 (28.5) 45 25.0 (24.0)
12 month change −51.1 (32.6) −46.9 (29.9) −52.9 (27.5)
>20 mm decrease 18 94.7 % 78 78 % 40 80 %
Change from baseline (p = .3708)§ p < .0001* p < .0001 p < .0001
ODI
 Baseline 20 52.2 (12.7) 100 55.0 (11.2) 52 56.7 (11.5)
 1 months 20 43.0 (16.9) 98 44.5 (16.9) 50 38.8 (18.3)
 3 months 20 37.6 (17.3) 99 33.1 (17.8) 50 33.8 (21.2)
 6 months 19 30.4 (20.0) 100 31.0 (18.7) 50 36.4 (21.4)
 12 months 17 32.8 (21.4) 95 30.8 (19.1) 46 31.9 (18.9)
 12 month change −20.6 (26.0) −24.1 (19.5) −24.6 (21.0)
Change from baseline (p = .3100) p < .0001 p < .0001 p < .0001
SF-36 PCS
 Baseline 20 32.0 (5.6) 98 31.1 (5.6) 51 32.7 (5.5)
 6 months 19 40.0 (11.1) 100 40.5 (9.2) 49 39.8 (10.1)
 12 months 17 41.6 (10.8) 91 40.0 (9.6) 46 40.5 (8.9)
 12 month change 10.4 (10.1) 8.7 (9.9) 8.1 (9.8)
Change from baseline (p = .3623) p < .0001 p < .0001 p < .0001
SF-36 MCS
 Baseline 20 42.2 (12.4) 98 37.7 (11.6) 51 38.6 (10.3)
 6 months 19 49.7 (9.6) 100 48.8 (10.8) 49 45.1 (13.2)
 12 months 17 49.0 (10.8) 91 47.7 (12.9) 46 48.0 (12.1)
 12 month change 7.2 (12.0) 10.2 (11.9) 8.2 (11.2)
Change from baseline (p = .1313) p < .0001 p < .0001 p < .0001
EQ-5D TTO
 Baseline 20 0.42 (0.14) 97 0.43 (0.18) 52 0.45 (0.19)
 6 months 19 0.72 (0.23) 98 0.70 (0.19) 50 0.64 (0.25)
 12 months 17 0.72 (0.21) 92 0.70 (0.20) 46 0.72 (0.19)
 12 month change 0.31 (0.29) 0.27 (0.24) 0.26 (0.24)
Change from baseline (p = .0446) p < .0001 p < .0001 p < .0001
PPGP No PPGP Men
N
Satisfaction at 12 months (p = .1252) 
 Very or somewhat satisfied 17 100 % 79 84.0 % 42 91.3 %
 No 0 0 % 15 16.0 % 4 8.7 %
Would have surgery again (p = .6503)
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in men. In the PPGP group, two subjects experienced a 
post-surgical wound infection. One subject complained 
of numbness at the surgical site. At 4  months after 
surgery, this same subject presented with pain second-
ary to a fall. CT imaging showed inadequate placement of 
the second and third implants. The subject was brought 
* Using repeated measures analysis of variance
§ Using repeated measures analysis of variance or chi-squared test
Table 4 continued
PPGP No PPGP Men
N
 Might or definitely yes 16 94.1 % 84 89.4 % 43 93.5%
 No 1 5.9 % 10 10.6 % 3 6.5 %
Fig. 2 Mean VAS SI joint pain by time across subgroups
Fig. 3 Mean Oswestry Disability Index by time across subgroups
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back to the operating room 13  months after the index 
procedure and one additional implant was placed. This 
subject subsequently experienced relief of symptoms. 
In the remaining subjects without PPGP, three subjects 
underwent subsequent revision (two women without 
PPGP, one man). Two revisions were immediate, in that 
subjects were brought back to the operating room soon 
after surgery in order to retract an implant that had vio-
lated the sacral neural foramen, resulting in symptomatic 
nerve impingement. One subject presented with pain at 
4  months after the index surgery. CT scan revealed the 
third implant was not across the joint. The implant was 
replaced with a longer device and one additional implant 
was placed. The revision rate was 5 % in PPGP subjects, 
2 % in women without PPGP and 1.9 % in men. The revi-
sion rate for all subjects in SIFI was 2.3  % (4/172). No 
subject experienced systemic complications, deep venous 
thrombosis or pulmonary embolism.
Discussion
Roughly 20 % of women who experience back pain dur-
ing pregnancy report persistent pain 2 and 3 years post-
partum (Norén et  al. 2002). A substantial proportion of 
pregnancy- and post-partum-related back pain origi-
nates in and around the SI joint. The SI joint is a highly 
innervated diarthroidal joint subject to high mechani-
cal stresses, especially during the peripartum period. 
Fig. 4 SF-36 scores by domain across subgroups
Table 5 Adverse events at 12-months
PPGP No PPGP Male
Total number of events 37 158 88
Event rate per subject, mean (SD) 1.8 (1.3) 1.6 (1.4) 1.7 (1.6)
Related to device/procedure 4 10 7
Wound infection 2 2
Buttock pain 0 2 1
Postoperative neuropathy 0 1 1
Postoperative nausea/vomiting 0 3 0
SI joint pain 0 0 2
Intraoperative hemorrhage 0 1 0
Numbness around surgical wound 1 0 0
Neuropathy after contralateral SI joint fusion 
revision
0 1 0
Staple irritation 0 0 1
Urinary retention 0 1 0
Wound drainage 0 1 0
Fall causing SI joint pain. Poor device place-
ment
1 0 0
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Its exact innervation is quite variable both within and 
between individuals. In general, innervation of the SI 
joint is provided by various branches emanating any-
where from L5-S4 (Vleeming et al. 2012; Dreyfuss et al. 
2003). These same segments also innervate muscles of 
the buttocks, hips and lower limbs. Furthermore, pain 
neurotransmitters, substance P, and calcitonin gene-
related polypeptide have been detected in the cartilage 
of both sides of the joint as well as in the surrounding 
ligaments (Vleeming et  al. 2012). Multisite injections of 
the sacral nerve roots can block some, but not all, elic-
ited SI joint pain (Dreyfuss et al. 2009). Clearly, there is a 
neuropathway for pain perception in the region of the SI 
joint as well as low back, buttock and groin.
SI joint disorders associated with pregnancy are likely 
multifactorial and can be caused by a combination of 
hormonal, biomechanical, traumatic and degenera-
tive factors. The design of the pelvic girdle provides the 
human body with both the stability needed to support 
the weight of the axial skeleton and the mobility required 
to accommodate habitual bipedal locomotion and child-
birth. The sacrum has been described as “floating” in the 
pelvic girdle, stabilized by an intricate web of strong liga-
ments. The unique shape of the auricular surfaces, char-
acterized by complimentary billowing and pitting, along 
with the basket weave of ligaments, creates self-bracing 
of the joint, referred to as form closure (Vleeming et al. 
1992). Force closure, characterized by muscle forces and 
ligament tension, is maintained through a myofascial net-
work spanning from the torso to the lower extremities. 
A small degree of mobility is observed via nutation and 
counternutation of the sacrum and vertical translation 
and compression of the pubic symphysis (Becker et  al. 
2010). Ligament loosening as a result of increased relaxin 
during pregnancy can create a cascade of events that can 
lead to degeneration or disruption of the SI joint. Liga-
ments are viscoelastic structures that creep and deform 
under constant load. Asymmetric ligament laxity will 
affect load transfer patterns, causing an imbalance in 
forces (Aldabe et  al. 2012). Additionally, pain in the SI 
joint can lead to inefficient muscle recruitment, prevent-
ing necessary force closure of the joint to maintain stabil-
ity (Agarwal et al. 2014).
Musculoskeletal structures are inherently unstable, 
allowing for agility critical to survival. The risk–benefit 
ratio is precariously held in balance—repeated assaults to 
the stability mechanism can have long-term degenerative 
effects (Gracovetsky 2007). A woman’s center of gravity 
shifts anteriorly both during pregnancy and post-partum 
while breast feeding, front baby carrying, and as a result 
of lifting, bending and lowering forces encountered dur-
ing daily activities of caring for an infant. The constant 
shift in the center of gravity may result in an anterior 
rotation of the innominates, potentially leading to a loos-
ening of the force couple, a decrease in intraarticular fric-
tion, and possible disruption or subsequent accelerated 
degeneration of the SI joint (DonTigny 2007).
Few effective non-surgical options are available for 
women with chronic, persistent PPGP related to the SI 
joint (Vleeming et  al. 2008). The largest body of avail-
able literature describes outcomes after physical therapy 
(PT) interventions. Dysfunction of load transfer in the 
pelvis as well as delayed onset of muscle activation has 
been well described as a possible explanation of PGP 
(Mens et al. 2001; Hungerford et al. 2003; Snijders et al. 
1993). This suggests that improvement in muscle activa-
tion and strength can alleviate pain. The current litera-
ture describes conflicting results. Four studies examined 
the effect of an intervention consisting of specific mus-
cle stabilizing exercises. One randomized study found 
that while active care consisting of stabilizing exercises, 
a pelvic belt and education appears to be effective in alle-
viating pain during pregnancy (Elden 2005), these same 
interventions did not prevent post-partum PGP (Elden 
2005; Elden et al. 2008). In another randomized trial com-
paring a program of various specific training exercises to 
no exercise, no difference was found between groups. 
Furthermore, while 64  % improved regardless of inter-
vention, 36 % either had no change in symptoms or felt 
worse after the treatment (Mens et al. 2001). One study 
found a 20-week program of specific stabilizing exercises 
to be effective and durable at relieving pain out to 2-years 
postpartum (Stuge et  al. 2004). However, a more recent 
study reported an individualized exercise program to be 
ineffective at relieving pain and back-related disability 
in women with persistent postpartum pelvic girdle pain, 
with or without concomitant low back pain (Gutke et al. 
2010). Thus the literature on physical therapy for PGP 
and PPGP conveys not only an unclear message about 
specific stabilizing exercises, but unclear guidance as to 
which exercises produced favorable results. It is clear that 
some women may benefit from this approach, but many 
will have continued pain and degradation in quality of 
life.
Controlled randomized trials of SI joint injections, 
both periarticular (methylprednisolone vs. sodium chlo-
ride) (Luukkainen et al. 2002), and intra-articular (carti-
vazol vs. saline) (Maugars et al. 1996) show modest initial 
improvement in symptoms followed by a quick, marked 
decline towards baseline levels by 6  months. Similarly, 
both case series and sham-controlled trials of RF dener-
vation report temporary improvement in less than half 
of subjects; success rates range from 36 to 47 % (Ferrante 
et al. 2001; Gevargez et al. 2002; Patel et al. 2012). None 
of these trials specifically enrolled women with PPGP as 
the cause of SI joint pain.
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Surgical arthrodesis in the spinal column is a com-
mon and accepted treatment in the presence of pathol-
ogy recalcitrant to conservative treatment modalities. 
Arthrodesis is the process of permanently joining 2 (or 
more) motion segments in order to eliminate pain caused 
by motion or abnormal loading of the joint. Success 
appears to largely depend on clear surgical indications 
and presence/absence of concomitant pathology and/or 
psychosocial factors (Spoor and Öner 2013). Pseudoar-
throsis, or failure to achieve permanent stabilization, is a 
well-documented cause of persistent pain postoperatively 
(Raizman et al. 2009). In a similar vein, fusion of the SI 
joint has been attempted. The first published report of 
SI joint fusion through a lateral approach was reported 
in 1921 (Smith-Petersen 1921). Since that time, the body 
of literature on open SI joint fusion has grown modestly 
and documents varying degrees of clinical effectiveness. 
Compared to more recent reports of minimally invasive 
approaches, open surgical techniques are associated with 
relatively long operative times, lengthy hospital stays, 
considerable soft tissue dissection, and non-weight bear-
ing for long periods of time (3  months). For these rea-
sons, open surgery of the SI joint is usually reserved for 
the most severe and complicated cases.
Several implants using a variety of MIS techniques 
are currently available for MIS SI joint fusion. SIFI is a 
prospective multicenter clinical trial of one such device 
(iFuse Implant System). A reasonably sized subgroup 
of patients in this study (17 % of women) reported pain 
onset in the peripartum period. These women showed 
improvements in pain, disability and quality of life after 
MIS SIJ fusion that were similar to both women without 
PPGP and men. Improvements in pain were clinically 
significant; 94.7  % achieved pre-defined success in pain 
improvement and the overall mean improvement was 
three times larger than that considered to be clinically 
meaningful (20-point improvement) (Copay et al. 2008). 
Similarly, improvements in function and quality of life 
were substantial, exceeding commonly acceptable values. 
The rate of adverse events in women with PPGP was rea-
sonably low.
The study reported herein has limitations. First, SIFI 
was not designed to diagnose PPGP. Some women who 
reported pain onset during pregnancy could have SI joint 
degeneration related to both peripartum disruption of 
the joint as well as subsequent joint degeneration as a 
result of age-related osteoarthritis or other factors such 
as adjacent segment degeneration after lumbar fusion 
(Weil et  al. 2008). No longitudinal studies have investi-
gated the long-term effects of peripartum SI joint disrup-
tion, but it is reasonable to assume that a large portion 
of affected patients will experience sequelae. Second, the 
number of subjects with PPGP was fairly low, limiting the 
ability to draw precise conclusions regarding differences 
in pain and QOL responses compared to the other sub-
groups. Nonetheless, no marked differences in pain relief 
and QOL improvement were seen across groups. Third, 
the study lacked a concomitant control group of women 
who received only non-surgical treatment. It is noted that 
all study participants had chronic (>6 months), carefully 
diagnosed SI joint pain and many had failed conservative 
treatment (medications, physical therapy, and, in some 
cases, RF ablation). Moreover, the mean duration of SI 
joint pain in PPGP subject was 6.3 years, suggesting both 
that treatments to date had not adequately relieved pain 
and that spontaneous pain relief with continued non-
surgical treatment would have been unlikely. The findings 
reported herein are encouraging and represent the first 
report of minimally invasive surgical treatment for unre-
mitting pain caused by SI joint dysfunction due to dis-
ruption or degeneration and associated with pregnancy. 
Physicians are encouraged to investigate the sacroiliac 
joint as a potential pain generator in patients presenting 
with persistent pelvic girdle pain. Moreover, further stud-
ies of minimally invasive SI joint fusion for the relief of 
post-partum-related SI joint pain are warranted.
Conclusion
The sacroiliac joint is a source of pain in approximately 
75  % of women with persistent PPGP. Physical therapy, 
the current mainstay of treatment, is an inconsist-
ent therapeutic option that may provide relief for some 
women and has been shown to exacerbate symptoms in 
others. For carefully selected women with chronic post-
partum related SI joint dysfunction recalcitrant to con-
servative therapies, MIS SI joint fusion may be a surgical 
option that has been shown to provide improvement in 
pain, disability and quality of life.
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